Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rebbeck

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology Reports|June 22, 2018
Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunitiesL Chuang, J Berek, T Randall, et al.
The Journal of Biological Chemistry|November 19, 2025
Large-scale high-throughput screen for cardiac ryanodine receptor targeted therapeuticsRoman Nikolaienko, Elisa Bovo, Jonathan C Solberg, et al.
Molecular Pharmacology|January 22, 2024
<i>ent</i>-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in <i>Casq2</i> <sup>-/-</sup> MiceAaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Dynamic-Structure Redesign of Calmodulin Reveals Mechanistic Constraints on Ryr2 RegulationVladimir Bogdanov, Svetlana Tikunova, Nicolas Fadell, et al.
Cell Calcium|August 12, 2019
The CaMKII inhibitor KN93-calmodulin interaction and implications for calmodulin tuning of Na<sub>V</sub>1.5 and RyR2 functionChristopher N Johnson, Rekha Pattanayek, Franck Potet, et al.
ACS Chemical Biology|September 28, 2023
RyR2 Binding of an Antiarrhythmic Cyclic Depsipeptide Mapped Using Confocal Fluorescence Lifetime Detection of FRETJaroslava Šeflová, Jacob A Schwarz, Abigail N Smith, et al.
Pharmacogenetics|October 23, 2001
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptivesI B Runnebaum, S Wang-Gohrke, D Vesprini, et al.
Circulation Research|October 15, 2025
Impaired Atrial Mitochondrial Calcium Handling in Patients With Atrial FibrillationJulius Ryan D Pronto, Fleur E Mason, Eva A Rog-Zielinska, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 26, 2001
Metabolic gene polymorphism frequencies in control populationsS Garte, L Gaspari, A K Alexandrie, et al.
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology Reports|June 22, 2018
Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunitiesL Chuang, J Berek, T Randall, et al.
The Journal of Biological Chemistry|November 19, 2025
Large-scale high-throughput screen for cardiac ryanodine receptor targeted therapeuticsRoman Nikolaienko, Elisa Bovo, Jonathan C Solberg, et al.
Molecular Pharmacology|January 22, 2024
<i>ent</i>-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in <i>Casq2</i> <sup>-/-</sup> MiceAaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Dynamic-Structure Redesign of Calmodulin Reveals Mechanistic Constraints on Ryr2 RegulationVladimir Bogdanov, Svetlana Tikunova, Nicolas Fadell, et al.
Cell Calcium|August 12, 2019
The CaMKII inhibitor KN93-calmodulin interaction and implications for calmodulin tuning of Na<sub>V</sub>1.5 and RyR2 functionChristopher N Johnson, Rekha Pattanayek, Franck Potet, et al.
ACS Chemical Biology|September 28, 2023
RyR2 Binding of an Antiarrhythmic Cyclic Depsipeptide Mapped Using Confocal Fluorescence Lifetime Detection of FRETJaroslava Šeflová, Jacob A Schwarz, Abigail N Smith, et al.
Pharmacogenetics|October 23, 2001
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptivesI B Runnebaum, S Wang-Gohrke, D Vesprini, et al.
Circulation Research|October 15, 2025
Impaired Atrial Mitochondrial Calcium Handling in Patients With Atrial FibrillationJulius Ryan D Pronto, Fleur E Mason, Eva A Rog-Zielinska, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 26, 2001
Metabolic gene polymorphism frequencies in control populationsS Garte, L Gaspari, A K Alexandrie, et al.
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
Pageof 6